(Hypertension. 2001;38:9.)
© 2001 American Heart Association, Inc.
Rapid Communications |
Microsatellite DNA Polymorphism of Human Adrenomedullin Gene in Normotensive Subjects and Patients With Essential Hypertension
From the Department of Hypertension and Cardiorenal Medicine (T.I., K.H., K.T., J.M., Y.F., H.O., H.M.), and Department of Health Care (M.O.), Dokkyo University School of Medicine, Mibu, Tochigi, Japan; and the Department of Biochemistry, National Cardiovascular Center Research Institute (J.H., K.K.), Suita, Osaka, Japan.
Correspondence to Toshihiko Ishimitsu, MD, Department of Hypertension and Cardiorenal Medicine, Dokkyo University School of Medicine, Mibu, Tochigi 321-0293, Japan. E-mail isimitu{at}dokkyomed.ac.jp
Abstract
Abstract—— Adrenomedullin (AM) is a hypotensive peptide widely produced in the cardiovascular organs and tissues. We have cloned and sequenced the genomic DNA encoding the human AM gene and have determined that the gene is located in the short arm of chromosome 11. The 3'-end of the gene is flanked by the microsatellite marker of cytosine adenine (CA) repeats. In this study, we investigated the association between DNA variations in AM gene and the predisposition to hypertension. Genomic DNA was obtained from 272 healthy normotensive subjects (NT) age 57±5 years and 266 patients with essential hypertension (EH) age 53±11 years. The DNA was subject to PCR using a fluorescence-labeled primer, and the number of CA repeats were determined by poly-acrylamide gel electrophoresis. The averaged blood pressure was 117±13/73±9 mm Hg in NT and 170±23/104±12 mm Hg in EH. In Japanese, there existed 4 types of alleles with different CA-repeat numbers: 11, 13, 14, and 19. The frequencies of these alleles were significantly different between NT and EH (
2=9.43, P=0.024). Namely, 13.5% of EH carried the 19-repeat allele, whereas the frequency was 6.2% in NT (2=7.62, P=0.007). In NT, plasma AM concentrations were not significantly different between the genotypes. In conclusion, microsatellite DNA polymorphism of AM gene may be associated with the genetic predisposition to EH, although the gene expression is not likely to be affected by the genotypes.
Key Words: adrenomedullin • polymorphism • hypertension, essential • microsatellite repeats • genetics
This article has been cited by other articles:
 |
|
 |
|
  A. M. Schultheis, G. Lurje, K. E. Rhodes, W. Zhang, D. Yang, A. A. Garcia, R. Morgan, D. Gandara, S. Scudder, A. Oza, et al. Polymorphisms and Clinical Outcome in Recurrent Ovarian Cancer Treated with Cyclophosphamide and Bevacizumab Clin. Cancer Res., November 15, 2008; 14(22): 7554 - 7563. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Bek, X. Wang, L. D. Asico, J. E. Jones, S. Zheng, X. Li, G. M. Eisner, D. K. Grandy, R. M. Carey, P. Soares-da-Silva, et al. Angiotensin-II Type 1 Receptor-Mediated Hypertension in D4 Dopamine Receptor-Deficient Mice Hypertension, February 1, 2006; 47(2): 288 - 295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Brain and A. D. Grant Vascular Actions of Calcitonin Gene-Related Peptide and Adrenomedullin Physiol Rev, July 1, 2004; 84(3): 903 - 934. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Harrap, V. R. Danes, J. A. Ellis, C. D. Griffiths, E. F. Jones, and L. M. D. Delbridge The hypertrophic heart rat: a new normotensive model of genetic cardiac and cardiomyocyte hypertrophy Physiol Genomics, April 10, 2002; 9(1): 43 - 48. [Abstract] [Full Text] [PDF]
|
|